Skip to Main Content
USF Health Morsani College of Medicine Research video

Shaping the future of health

Laura Bohn smiling wearing a USF Health branded medical white coat with a green blouse

The Morsani College of Medicine has active research programs in basic, translational, and clinical sciences. Research is carried out in Departments, Institutes, Centers and at our Veterans Hospitals and our primary teaching facility, Tampa General Hospital. In addition, there are rich collaborations with the Colleges of Public Health, Nursing and Pharmacy as well as the USF College of Arts and Sciences.

Our goal is to pursue new knowledge in the biomedical sciences, clinical sciences, and healthcare delivery, relevant to human health and disease. Please explore our research initiatives using the tabs above. The resources tab provides information for current faculty to facilitate research efforts.

Laura M. Bohn, PhD 
Senior Associate Vice President of Research, USF Health
Vice Dean for Research, Morsani College of Medicine
Professor, Molecular Pharmacology & Physiology
Email: lbohn@usf.edu

Research Day

Our annual celebration of groundbreaking research and scientific excellence continues - March 5, 2027

Celebrating health science research

Despite their different questions and disciplines, they shared a common goal: advancing the science that shapes how people live and receive care.

Those conversations, and hundreds more like them, filled the USF Marshall Student Center during the 36th annual USF Health Research Day, the university’s largest celebration of health sciences research.

Read more about USF Health Research Day 2026.

Health Science Innovation

Bayesian reweighting of α-synuclein ensembles reveals local-global discrepancies between chemical shifts and chain dimensions

Bayesian reweighting of α-synuclein ensembles reveals local-global discrepancies between chemical shifts and chain dimensions

α-Synuclein is an intrinsically disordered protein whose ensemble is shaped by both local structural preferences and global chain dimensions. Here, we combined BioMatics/AlphaFold2/AFflecto-derived structures with molecular dynamics simulations to generate a pool of α-synuclein conformations. Predicted chemical shifts were reweighted against experimental NMR chemical shifts using Bayesian Maximum Entropy reweighting. Global analyses showed that MD conformations remained compact and internally...

Treatment intensity and survival benefit among older adults with glioblastoma: A population-based analysis

Treatment intensity and survival benefit among older adults with glioblastoma: A population-based analysis

CONCLUSION: In this SEER-based cohort, more intensive initial multimodality management was associated with greater survival time accrued within 24 months even at advanced age. Given unmeasured confounding and potential immortal time bias inherent to registry treatment classification, these findings support individualized consideration of multimodality therapy in appropriately selected older adults rather than reliance on chronological age alone.

Frailty Measures for Adult Patients and Outcomes for Vestibular Schwannoma Surgeries: A Retrospective Cohort Study

Frailty Measures for Adult Patients and Outcomes for Vestibular Schwannoma Surgeries: A Retrospective Cohort Study

CONCLUSION: In VS microsurgery, tumor size rather than frailty was the dominant correlate of early postoperative outcomes after adjustment. Because frailer patients are often selected out before elective surgery, the null adjusted association does not prove frailty is clinically irrelevant but reflects its limited incremental value among already-fit patients. Counseling should prioritize tumor characteristics and surgical approach. These hypothesis-generating findings warrant prospective...